AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 131 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,970,469 | +2.7% | 639,700 | +27.9% | 0.44% | +178.6% |
Q2 2023 | $4,840,000 | +107.3% | 500,000 | +165.1% | 0.16% | +123.9% |
Q1 2022 | $2,335,000 | -40.3% | 188,621 | -37.3% | 0.07% | -78.4% |
Q1 2021 | $3,908,000 | +97600.0% | 300,988 | +100229.3% | 0.33% | +32800.0% |
Q1 2020 | $4,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |